Publications by authors named "M Weichenthal"

Claim this Profile
E
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg.
Noah Zimmermann, Julian Kött, Tim Zell, Ali Zeinal Abedini, Chiara L Blomen, Michael Weichenthal

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy.
S Dugas-Breit, A Forschner, M Erdmann, R Gutzmer, K C Kähler, M Weichenthal

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, Miriam Mengoni, Thomas Tüting, Michael Weichenthal

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression.
Sina Kaiser, Ina Suhrkamp, Jinru He, Charlotte Helf, Christian D Sadik, Michael Weichenthal

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, Michael Weichenthal, Peter Mohr

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis